本页面由Tiger Trade Technology Pte. Ltd.提供服务

Neurosense Therapeutics Ltd

1.02
0.0000
盘后1.01-0.0100-0.98%19:03 EST
成交量:16.14万
成交额:16.50万
市值:3,377.51万
市盈率:-2.70
高:1.06
开:1.05
低:0.9906
收:1.02
52周最高:2.60
52周最低:0.6801
股本:3,311.28万
流通股本:2,210.79万
量比:1.05
换手率:0.73%
股息:- -
股息率:- -
每股收益(TTM):-0.3778
每股收益(LYR):-0.5489
净资产收益率:-2478.16%
总资产收益率:-303.90%
市净率:-65.08
市盈率(LYR):-1.86

数据加载中...

2025/08/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/04/07

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/16

SEC问询函

Form CORRESP - Correspondence
2025/01/06

SEC问询函

Form CORRESP - Correspondence
2024/12/13

SEC问询函

Form CORRESP - Correspondence
2024/12/09

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/22

SEC问询函

Form CORRESP - Correspondence
2024/11/19

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/05/21

SEC问询函

Form CORRESP - Correspondence
2024/05/20

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/10

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/04/04

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/04

SEC问询函

Form CORRESP - Correspondence
2023/09/01

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/08/31

SEC问询函

Form CORRESP - Correspondence
2023/08/15

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/08/14

SEC问询函

Form CORRESP - Correspondence
2023/07/21

招股说明书

Form F-1 - Registration statement for certain foreign private issuers